Advanced search
Publication Cover
Drug Delivery Volume 23, 2016 - Issue 8
Submit an article Journal homepage
1,557
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations

Mohammad TariqDepartment of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India,
,
Md. Aftab AlamDepartment Pharmacy, Galgotia University, Greater Noida, India,
,
Anu T SinghDabur Research Foundation, Sahibabad, Ghaziabad, Uttar Pradesh, India, and
,
Amulya K PandaNational Institute of Immunology, New Delhi, India
&
Sushama TalegaonkarDepartment of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India, Correspondence[email protected] stalegaonkar@[email protected]
Pages 2990-2997 | Received 12 Nov 2015, Accepted 23 Dec 2015, Published online: 22 Jan 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Leonardo Delello Di Filippo, Alberto Gomes Tavares Junior, Larissa Bueno Tofani, Juliana Maldonado Marchetti & Marlus Chorilli. (2023) Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. Critical Reviews in Analytical Chemistry 53:5, pages 1080-1093.
Read now

Articles from other publishers (8)

Solomon Owumi, Uche Arunsi, Moses Otunla, Grace Adebisi, Ahmad Altayyar & Chioma Irozuru. (2023) 3-Indolepropionic acid mitigates sub-acute toxicity in the cardiomyocytes of epirubicin-treated female rats. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Radwan Ansaar, Robyn Meech & Andrew Rowland. (2023) A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution. Pharmaceutics 15:4, pages 1222.
Crossref
M.E. Abdel-Hameed, Nourihan S. Farrag, H. Aglan, Abeer M. Amin & M.A. Mahdy. (2022) A new modality in targeted delivery of epirubicin for tumor theranosis based on PEGylated silver nanoparticles: Design, radiolabeling and bioevaluation. International Journal of Pharmaceutics 629, pages 122358.
Crossref
M.E. Abdel-Hameed, Nourihan S. Farrag, H. Aglan, Abeer M. Amin & M.A. Mahdy. (2022) Improving the tumor targeting efficiency of epirubicin via conjugation with radioiodinated poly (vinyl alcohol)-coated silver nanoparticles. Journal of Drug Delivery Science and Technology 76, pages 103781.
Crossref
Fatemeh Fathian kolahkaj, Katayoun Derakhshandeh, Farnaz Khaleseh, Abbas Hemmati Azandaryani, Kamran Mansouri & Mozafar Khazaei. (2019) Active targeting carrier for breast cancer treatment: Monoclonal antibody conjugated epirubicin loaded nanoparticle. Journal of Drug Delivery Science and Technology 53, pages 101136.
Crossref
Sajini D. Hettiarachchi, Regina M. Graham, Keenan J. Mintz, Yiqun Zhou, Steven Vanni, Zhilli Peng & Roger M. Leblanc. (2019) Triple conjugated carbon dots as a nano-drug delivery model for glioblastoma brain tumors. Nanoscale 11:13, pages 6192-6205.
Crossref
Nikos K. Karamanos, Zoi Piperigkou, Achilleas D. Theocharis, Hideto Watanabe, Marco Franchi, Stéphanie Baud, Stéphane Brézillon, Martin Götte, Alberto Passi, Davide Vigetti, Sylvie Ricard-Blum, Ralph D. Sanderson, Thomas Neill & Renato V. Iozzo. (2018) Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics. Chemical Reviews 118:18, pages 9152-9232.
Crossref
Regina M. Graham, Emel Kirbas Cilingir, Sajini D. Hettiarachchi, Yiqun Zhou, Braulio CLB Ferreira, Steven Vanni & Roger M. Leblanc. (2022) Carbon Dot Nanoarchitectonics: Quadruple Conjugated Nano Model for Superior Cancer Cell-Nucleus Targeting and Multi Drug Delivery. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.